Clinical Trial Update: Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating chemotherapy in combination with bemcentinib for metastatic pancreatic cancer was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bemcentinib (bemcentinib)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cancer of Pancreas | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-11-09